Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak

In late 2019, the coronavirus disease 2019 (COVID-19) broke out in Wuhan and then spread over China, which greatly affected the medical practices and health care systems. With most of the hospital’s outpatient services closed, the routine clinical diagnosis and treatment for patients with dermatomyo...

Descripción completa

Detalles Bibliográficos
Autores principales: Pi, Zixin, Chen, Pan, Zhan, Yi, Xiao, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
COVID-19: Important Updates and Developments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403873/
https://www.ncbi.nlm.nih.gov/pubmed/33341205
http://dx.doi.org/10.1016/j.clindermatol.2020.08.004
_version_ 1783567027284213760
author Pi, Zixin
Chen, Pan
Zhan, Yi
Xiao, Rong
author_facet Pi, Zixin
Chen, Pan
Zhan, Yi
Xiao, Rong
author_sort Pi, Zixin
collection PubMed
description In late 2019, the coronavirus disease 2019 (COVID-19) broke out in Wuhan and then spread over China, which greatly affected the medical practices and health care systems. With most of the hospital’s outpatient services closed, the routine clinical diagnosis and treatment for patients with dermatomyositis has been disturbed. We conducted telephone follow-up for 52 patients to know the changes in the condition and the continuation of drug therapy and to ensure the continuity, safety, and effectiveness of the treatment of patients with dermatomyositis during COVID-19.
format Online
Article
Text
id pubmed-7403873
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74038732020-08-05 Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak Pi, Zixin Chen, Pan Zhan, Yi Xiao, Rong Clin Dermatol COVID-19: Important Updates and Developments In late 2019, the coronavirus disease 2019 (COVID-19) broke out in Wuhan and then spread over China, which greatly affected the medical practices and health care systems. With most of the hospital’s outpatient services closed, the routine clinical diagnosis and treatment for patients with dermatomyositis has been disturbed. We conducted telephone follow-up for 52 patients to know the changes in the condition and the continuation of drug therapy and to ensure the continuity, safety, and effectiveness of the treatment of patients with dermatomyositis during COVID-19. Elsevier Inc. 2020 2020-08-05 /pmc/articles/PMC7403873/ /pubmed/33341205 http://dx.doi.org/10.1016/j.clindermatol.2020.08.004 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle COVID-19: Important Updates and Developments
Pi, Zixin
Chen, Pan
Zhan, Yi
Xiao, Rong
Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
title Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
title_full Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
title_fullStr Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
title_full_unstemmed Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
title_short Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
title_sort management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
topic COVID-19: Important Updates and Developments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403873/
https://www.ncbi.nlm.nih.gov/pubmed/33341205
http://dx.doi.org/10.1016/j.clindermatol.2020.08.004
work_keys_str_mv AT pizixin managementstrategiesfordermatomyositisduringthecoronavirusdisease2019outbreak
AT chenpan managementstrategiesfordermatomyositisduringthecoronavirusdisease2019outbreak
AT zhanyi managementstrategiesfordermatomyositisduringthecoronavirusdisease2019outbreak
AT xiaorong managementstrategiesfordermatomyositisduringthecoronavirusdisease2019outbreak

Ejemplares similares